On the public citation graph

A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs

0 signed · 43 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s10875-021-00997-6openalex-snapshot
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
inferredcites →https://doi.org/10.1016/0022-1759(87)90289-4openalex-snapshot
Statistical considerations in the quantitation of serum immunoglobulin levels using the Enzyme-Linked Immunosorbent Assay (ELISA)
inferredcites →https://doi.org/10.1016/bs.aivir.2018.01.001openalex-snapshot
Hosts and Sources of Endemic Human Coronaviruses
inferredcites →https://doi.org/10.1016/j.cell.2021.02.010openalex-snapshot
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
inferredcites →https://doi.org/10.1016/j.eclinm.2021.100734openalex-snapshot
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
inferredcites →https://doi.org/10.1016/j.ijid.2020.10.104openalex-snapshot
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa
inferredcites →https://doi.org/10.1016/j.jcv.2007.08.007openalex-snapshot
Seroepidemiology of group I human coronaviruses in children
inferredcites →https://doi.org/10.1016/j.jviromet.2015.02.014openalex-snapshot
Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses
inferredcites →https://doi.org/10.1016/j.mayocp.2020.05.032openalex-snapshot
Seasonality of Coronavirus 229E, HKU1, NL63, and OC43 From 2014 to 2020
inferredcites →https://doi.org/10.1016/j.tim.2016.03.003openalex-snapshot
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
inferredcites →https://doi.org/10.1016/s0022-1759(98)00170-7openalex-snapshot
A statistically defined endpoint titer determination method for immunoassays
inferredcites →https://doi.org/10.1016/s0929-6646(09)60066-8openalex-snapshot
Human Coronaviruses 229E and NL63: Close Yet Still So Far
inferredcites →https://doi.org/10.1038/s41467-021-23074-3openalex-snapshot
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
inferredcites →https://doi.org/10.1038/s41591-020-0913-5openalex-snapshot
A serological assay to detect SARS-CoV-2 seroconversion in humans
inferredcites →https://doi.org/10.1056/nejmoa2001017openalex-snapshot
A Novel Coronavirus from Patients with Pneumonia in China, 2019
inferredcites →https://doi.org/10.1080/22221751.2021.1905488openalex-snapshot
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
inferredcites →https://doi.org/10.1093/infdis/jiaa680openalex-snapshot
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
inferredcites →https://doi.org/10.1093/infdis/jiab333openalex-snapshot
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples
inferredcites →https://doi.org/10.1097/inf.0000000000002660openalex-snapshot
Coronavirus Infections in Children Including COVID-19
inferredcites →https://doi.org/10.1101/2020.10.10.20210070openalex-snapshot
Severe COVID-19 patients display a back boost of seasonal coronavirus-specific antibodies
inferredcites →https://doi.org/10.1126/science.abd0826openalex-snapshot
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
inferredcites →https://doi.org/10.1128/jcm.00533-08openalex-snapshot
Human Coronavirus NL63 and 229E Seroconversion in Children
inferredcites →https://doi.org/10.1128/jcm.00636-10openalex-snapshot
Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method
inferredcites →https://doi.org/10.1172/jci146927openalex-snapshot
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
inferredcites →https://doi.org/10.1371/journal.pone.0131080openalex-snapshot
Biodiversity on the Rocks: Macrofauna Inhabiting Authigenic Carbonate at Costa Rica Methane Seeps
inferredcites →https://doi.org/10.1371/journal.pone.0146021openalex-snapshot
Dose-Response Analysis Using R
inferredcites →https://doi.org/10.2139/ssrn.3676223openalex-snapshot
Cross-Reactive Antibody Against Human Coronavirus OC43 Spike Protein Correlates with Disease Severity in COVID-19 Patients: A Retrospective Study
inferredcites →https://doi.org/10.3390/microorganisms8121993openalex-snapshot
HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic
inferredcites →https://doi.org/10.3791/54573openalex-snapshot
Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
inferredcites →https://doi.org/10.7717/peerj-cs.1516openalex-snapshot
PyMC: a modern, and comprehensive probabilistic programming framework in Python
inferredcites →https://doi.org/10.7717/peerj-cs.55openalex-snapshot
Probabilistic programming in Python using PyMC3

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4647916openalex-extracted
Choosing Sides: Comparing Ipsilateral and Contralateral Coadministration of Influenza and COVID-19 Vaccines
inferred← citeshttps://doi.org/10.1007/s10265-026-01700-9openalex-snapshot
Quantitative western blotting adapted for expanded sample capacity with non-linear curve fitting
inferred← citeshttps://doi.org/10.1016/j.ebiom.2024.105103openalex-snapshot
Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses
inferred← citeshttps://doi.org/10.1016/j.ijoes.2026.101321openalex-snapshot
Sensitive voltammetric determination of matrine using a nitrogen-doped graphene/zinc oxide nanocomposite modified electrode
inferred← citeshttps://doi.org/10.1016/j.isci.2025.113386openalex-snapshot
Emergence of SARS-CoV-2 Omicron lineages shifted antibody-mediated protection curves
inferred← citeshttps://doi.org/10.1016/j.omtm.2024.101286openalex-snapshot
Evaluation of anti-vector immune responses to adenovirus-mediated lung gene therapy and modulation by αCD20
inferred← citeshttps://doi.org/10.1093/aje/kwae125openalex-snapshot
SARS-CoV-2 incidence, seroprevalence, and antibody dynamics in a rural, population-based cohort: March 2020–July 2022
inferred← citeshttps://doi.org/10.1111/irv.12970openalex-snapshot
mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
inferred← citeshttps://doi.org/10.1111/irv.13104openalex-snapshot
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
inferred← citeshttps://doi.org/10.33029/0206-4952-2022-43-4-447-457openalex-snapshot
Flow cytometric assay for the detection of anti-SARS-CoV-2 Spike protein antibodies in serum of vaccinated volunteers
inferred← citeshttps://doi.org/10.3390/diseases13090276openalex-snapshot
Titers of IgG, IgM, and IgA Against SARS-CoV-2 in Healthcare Workers from a General Hospital in Mexico City
inferred← citeshttps://doi.org/10.3390/vaccines13030268openalex-snapshot
SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.